SEARCH EISAI MEDICAL INFORMATION:

Product name*
HALAVEN® (eribulin mesylate)
LENVIMA® (lenvatinib)

*required fields

Please do not include these characters in your search (,),*,-

Please verify spelling of your keywords before submitting

Please provide an input in all required fields

Loading results ....
Please provide an input in all required fields

Please refine your search criteria or submit a medical inquiry.

Eisai does not recommend or endorse the use of this investigational agent in any manner as it has not been approved by the U.S. Food and Drug Administration. This information discusses investigational agents/uses of an agent in development and is not intended to convey conclusions about efficacy, safety, or appropriate use. There is no guarantee that such agent will successfully complete clinical development or gain health authority approval.

Eisai does not recommend or endorse the use of this investigational agent in any manner as it has not been approved by the U.S. Food and Drug Administration. This information discusses investigational agents/uses of an agent in development and is not intended to convey conclusions about efficacy, safety, or appropriate use. There is no guarantee that such agent will successfully complete clinical development or gain health authority approval.

Please refine your search criteria or submit a medical inquiry.

Search result(s) may include information that is not consistent with the product's Full Prescribing Information. Eisai does not recommend uses that are inconsistent with the Full Prescribing Information.


TO REPORT SUSPECTED ADVERSE EVENTS OR PRODUCT COMPLAINTS, PLEASE CALL 1-888-274-2378. YOU MAY ALSO REPORT SUSPECTED ADVERSE EVENTS TO THE FDA BY CALLING 1-800-FDA-1088 OR CLICK HERE